Amedeo Smart

Free Medical Literature Service

 

Amedeo

Parkinson's Disease
  Free Subscription

Articles published in
Neurochem Res
    September 2025
  1. WANKHEDE M, Rathod K, Aswar M, Aswar U, et al
    Stigmasterol Alleviates Levodopa-Induced Dyskinesia in 6-OHDA-Induced Parkinsonian Rats.
    Neurochem Res. 2025;50:304.
    >> Share

  2. ZHU L, Lin L, Yang Z, Tang H, et al
    Sinomenine Modifies Parkinson's Disease Through Nrf2 Activation.
    Neurochem Res. 2025;50:302.
    >> Share

  3. MEKHLOUF YE, Bouhaddou N, Dimaoui A, Ittorahou A, et al
    Therapeutic Effect of Physical Activity in a Male Wistar Rat Model of Paraquat and Maneb-Induced Parkinson's Disease.
    Neurochem Res. 2025;50:294.
    >> Share

    August 2025
  4. DESHPANDE V, Schick K, Mazumder P, Dutta AK, et al
    Biological Characterization of the Anti-ferroptotic Properties of a Novel Anti-Parkinsonian Iron (II) Selective Dopamine Agonist, D-583.
    Neurochem Res. 2025;50:264.
    >> Share

    June 2025
  5. CHEN P, Yang J, Xu Y, Chen J, et al
    MicroRNA-361-3p Regulates Autophagy and Apoptotic Processes by Regulating PI3K/Akt Signaling in Parkinson's Disease.
    Neurochem Res. 2025;50:221.
    >> Share

  6. ABD EL-KHALIK SR, AbuoHashish NA, Nasif E, Arakeep HM, et al
    Possible Mitigating Effect of Nobiletin on Rotenone-Induced Parkinsonism in Male Albino Rat Model: Targeting Bmal1/Nrf2 Mediated Ferroptosis and Restoring Mitochondrial Mitophagy.
    Neurochem Res. 2025;50:208.
    >> Share

    May 2025
  7. NI Y, Hayat MA, Si Y, Guo T, et al
    Protective Effect of FABP5 Against 6-OHDA Induced Parkinson's Disease Via PPARgamma/SIRT1/PGC-1alpha Signaling Pathway.
    Neurochem Res. 2025;50:177.
    >> Share

  8. CHINNAPPAN D, Krishnan M, Kuppamuthu A, Elangovan N, et al
    Developmental and Neuroprotective Effects of alpha-Terpineol in MPTP-Induced Parkinsonism in Zebrafish Larvae.
    Neurochem Res. 2025;50:158.
    >> Share

    April 2025
  9. LEE C, Kim SS, Bae MA, Kim SH, et al
    Neuroprotective Activities of Sertraline, Tiagabine, and Bicifadine with Autophagy-Inducing Potentials in a 6-Hydroxidopamine-Treated Parkinson's Disease Cell Model.
    Neurochem Res. 2025;50:154.
    >> Share

  10. SAHOO TA, Chand J, Kandy AT, Antony S, et al
    Unravelling the Proteinopathic Engagement of alpha-Synuclein, Tau, and Amyloid Beta in Parkinson's Disease: Mitochondrial Collapse as a Pivotal Driver of Neurodegeneration.
    Neurochem Res. 2025;50:145.
    >> Share

  11. ZHAO X, Cao R, Tian X, Liu P, et al
    OAB-14 Attenuated Glymphatic System Disorder, Neuroinflammation and Dyskinesia in Parkinson's Disease Model Mice Induced by Rotenone.
    Neurochem Res. 2025;50:142.
    >> Share

    November 2024
  12. KHODIR SA, Sweed EM, Faried MA, Abo Elkhair DM, et al
    Neuroprotective Effect of Maresin-1 in Rotenone-Induced Parkinson's Disease in Rats: The Putative Role of the JAK/STAT Pathway.
    Neurochem Res. 2024;50:30.
    >> Share

  13. CHEN Y, Gu Y, Cao C, Zheng Q, et al
    Exploring alpha-synuclein Interaction Partners and their Potential Clinical Implications for Parkinson's Disease.
    Neurochem Res. 2024;50:23.
    >> Share

  14. GAO Y, Li S, Zhang S, Zhang Y, et al
    Atractylenolide-I Attenuates MPTP/MPP(+)?Mediated Oxidative Stress in Parkinson's Disease Through SIRT1/PGC?1alpha/Nrf2 Axis.
    Neurochem Res. 2024;50:18.
    >> Share

    August 2024
  15. MUHAMMAD AJ, Al-Baqami FF, Alanazi FE, Alattar A, et al
    The Interplay of Carveol and All-Trans Retinoic Acid (ATRA) in Experimental Parkinson's Disease: Role of Inflammasome-Mediated Pyroptosis and Nrf2.
    Neurochem Res. 2024 Aug 27. doi: 10.1007/s11064-024-04226.
    >> Share

  16. AZIZIFAR N, Mohaddes G, Keyhanmanesh R, Athari SZ, et al
    Intranasal AdipoRon Mitigated Anxiety and Depression-Like Behaviors in 6-OHDA-Induced Parkinson 's Disease Rat Model: Going Beyond Motor Symptoms.
    Neurochem Res. 2024 Aug 3. doi: 10.1007/s11064-024-04223.
    >> Share

  17. PEREZ VISNUK D, LeBlanc JG, de Moreno de LeBlanc A
    Neuroprotective Effects Exerted by a Combination of Selected Lactic Acid Bacteria in a Mouse Parkinsonism Model under Levodopa-Benserazide Treatment.
    Neurochem Res. 2024 Aug 1. doi: 10.1007/s11064-024-04217.
    >> Share

    May 2024
  18. THIRUPATHI A, Marqueze LF, Outeiro TF, Radak Z, et al
    Physical Exercise-Induced Activation of NRF2 and BDNF as a Promising Strategy for Ferroptosis Regulation in Parkinson's Disease.
    Neurochem Res. 2024 May 24. doi: 10.1007/s11064-024-04152.
    >> Share

    April 2024
  19. VASUDEVAN SAJINI D, Thaggikuppe Krishnamurthy P, Chakkittukandiyil A, Mudavath RN, et al
    Correction: Orientin Modulates Nrf2-ARE, PI3K/Akt, JNK-ERK1/2, and TLR4/NF-kB Pathways to Produce Neuroprotective Benefits in Parkinson's Disease.
    Neurochem Res. 2024 Apr 16. doi: 10.1007/s11064-024-04138.
    >> Share

  20. PERLIKOWSKA R, Silva J, Alves C, Susano P, et al
    Neuroprotective and Anti-inflammatory Effects of Rubiscolin-6 Analogs with Proline Surrogates in Position 2.
    Neurochem Res. 2024;49:895-918.
    >> Share

    March 2024
  21. ZHAO J, Wang J, Zhao K, Zhang Y, et al
    Protopanaxadiols Eliminate Behavioral Impairments and Mitochondrial Dysfunction in Parkinson's Disease Mice Model.
    Neurochem Res. 2024 Mar 29. doi: 10.1007/s11064-024-04132.
    >> Share

  22. KRYL'SKII ED, Razuvaev GA, Popova TN, Oleinik SA, et al
    6-Hydroxy-2,2,4-trimethyl-1,2,3,4-tetrahydroquinoline Demonstrates Neuroprotective Properties in Experimental Parkinson's Disease by Enhancing the Antioxidant System, Normalising Chaperone Activity and Suppressing Apoptosis.
    Neurochem Res. 2024 Mar 19. doi: 10.1007/s11064-024-04125.
    >> Share

  23. ESTEVES M, Cristovao AC, Vale A, Machado-Pereira M, et al
    MicroRNA-124-3p Modulates Alpha-Synuclein Expression Levels in a Paraquat-Induced in vivo Model for Parkinson's Disease.
    Neurochem Res. 2024 Mar 7. doi: 10.1007/s11064-024-04130.
    >> Share

    February 2024
  24. SHEN J, Chen S, Li X, Wu L, et al
    Salidroside Mediated the Nrf2/GPX4 Pathway to Attenuates Ferroptosis in Parkinson's Disease.
    Neurochem Res. 2024 Feb 29. doi: 10.1007/s11064-024-04116.
    >> Share

  25. XU F, Bian N, Li X
    SNHG14 Elevates NFAT5 Expression Through Sequestering miR-375-3p to Promote MPP + -Induced Neuronal Apoptosis, Inflammation, and Oxidative Stress in Parkinson's Disease.
    Neurochem Res. 2024 Feb 21. doi: 10.1007/s11064-024-04106.
    >> Share

  26. YANG J, Du C, Li Y, Liu R, et al
    Contrasting Iron Metabolism in Undifferentiated Versus Differentiated MO3.13 Oligodendrocytes via IL-1beta-Induced Iron Regulatory Protein 1.
    Neurochem Res. 2024;49:466-476.
    >> Share

    January 2024
  27. VASUDEVAN SAJINI D, Thaggikuppe Krishnamurthy P, Chakkittukandiyil A, Mudavath RN, et al
    Orientin Modulates Nrf2-ARE, PI3K/Akt, JNK-ERK1/2, and TLR4/NF-kB Pathways to Produce Neuroprotective Benefits in Parkinson's Disease.
    Neurochem Res. 2024 Jan 26. doi: 10.1007/s11064-024-04099.
    >> Share

  28. DE ASSIS ALC, de Araujo Rodrigues P, de Morais SM, Rodrigues ALM, et al
    Byrsonima sericea Ethanol Extract Protected PC12 Cells from the Oxidative Stress and Apoptosis Induced by 6-Hydroxydopamine.
    Neurochem Res. 2024;49:234-244.
    >> Share

  29. NISHIGUCHI H, Omura T, Sato A, Kitahiro Y, et al
    Luteolin Protects Against 6-Hydoroxydopamine-Induced Cell Death via an Upregulation of HRD1 and SEL1L.
    Neurochem Res. 2024;49:117-128.
    >> Share

    August 2023
  30. HE ZQ, Huan PF, Wang L, He JC, et al
    Compound Dihuang Granule Changes Gut Microbiota of MPTP-Induced Parkinson's Disease Mice via Inhibiting TLR4/NF-kappaB Signaling.
    Neurochem Res. 2023 Aug 10. doi: 10.1007/s11064-023-04004.
    >> Share

  31. DA CRUZ GUEDES E, Erustes AG, Leao AHFF, Carneiro CA, et al
    Cannabidiol Recovers Dopaminergic Neuronal Damage Induced by Reserpine or alpha-synuclein in Caenorhabditis elegans.
    Neurochem Res. 2023;48:2390-2405.
    >> Share

    July 2023
  32. TIWARI S, Gupta P, Singh A, Chaturvedi S, et al
    Correction to: 4-Phenylbutyrate Mitigates the Motor Impairment and Dopaminergic Neuronal Death During Parkinson's Disease Pathology via Targeting VDAC1 Mediated Mitochondrial Function and Astrocytes Activation.
    Neurochem Res. 2023 Jul 5. doi: 10.1007/s11064-023-03975.
    >> Share

    May 2023
  33. SIDDIQUI T, Bhatt LK
    Targeting Sigma-1 Receptor: A Promising Strategy in the Treatment of Parkinson's Disease.
    Neurochem Res. 2023 May 31:1-11. doi: 10.1007/s11064-023-03960.
    >> Share

  34. SHARMA M, Sharma N, Khairnar A
    Intranasal Rotenone Induces Alpha-Synuclein Accumulation, Neuroinflammation and Dopaminergic Neurodegeneration in Middle-Aged Mice.
    Neurochem Res. 2023;48:1543-1560.
    >> Share

    March 2023
  35. CHITHRA Y, Dey G, Ghose V, Chandramohan V, et al
    Mitochondrial Complex I Inhibition in Dopaminergic Neurons Causes Altered Protein Profile and Protein Oxidation: Implications for Parkinson's disease.
    Neurochem Res. 2023 Mar 25. doi: 10.1007/s11064-023-03907.
    >> Share

  36. MORADI VASTEGANI S, Nasrolahi A, Ghaderi S, Belali R, et al
    Mitochondrial Dysfunction and Parkinson's Disease: Pathogenesis and Therapeutic Strategies.
    Neurochem Res. 2023 Mar 21. doi: 10.1007/s11064-023-03904.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016